| Livtencity (maribavir) / Takeda, GSK |
NCT06034925: Maribavir Vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients |
|
|
| Active, not recruiting | 4 | 70 | US | Maribavir, Valganciclovir | Medical University of South Carolina, Takeda | Transplant Complication, CMV | 11/25 | 11/25 | | |
| Completed | 3 | 41 | Japan | Maribavir, SHP620, TAK-620 | Takeda, Takeda Pharmaceutical Company Limited | Cytomegalovirus (CMV) | 06/23 | 06/23 | | |
NCT06439342: A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections |
|
|
| Recruiting | 3 | 20 | RoW | Maribavir, TAK-620 | Takeda | Cytomegalovirus (CMV) | 12/26 | 12/26 | | |
TAK-620-2004, NCT05319353 / 2021-004279-15: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT) |
|
|
| Active, not recruiting | 3 | 80 | Europe, Japan, US, RoW | Maribavir, TAK-620 | Takeda, Takeda Development Center Americas, Inc. | Cytomegalovirus (CMV) | 01/27 | 01/27 | | |
NCT05918822: A Study of Maribavir Pediatric Formulation in Healthy Adult Participants |
|
|
| Completed | 1 | 32 | US | Maribavir Commercial Tablet Formulation, TAK-620, Maribavir Pediatric Powder-for-oral Suspension Formulation, Rabeprazole | Takeda | Healthy Volunteers | 08/23 | 09/23 | | |
| Recruiting | N/A | 250 | Japan | Maribavir | Takeda | Cytomegalovirus (CMV) | 08/31 | 08/31 | | |
NCT06213974: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Argentina |
|
|
| Recruiting | N/A | 10 | RoW | No Intervention | Takeda | Cytomegalovirus (CMV) | 06/26 | 09/26 | | |
| Recruiting | N/A | 150 | Europe, RoW | No Intervention | Takeda | Cytomegalovirus (CMV) | 04/25 | 04/25 | | |
NCT06555432: A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea |
|
|
| Not yet recruiting | N/A | 168 | NA | LIVTENCITY, Maribavir | Takeda | Cytomegalovirus (CMV) | 10/28 | 10/28 | | |
MARIBEL, NCT06677892: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium |
|
|
| Recruiting | N/A | 75 | Europe | No Intervention | Takeda | Cytomegalovirus (CMV) | 08/26 | 09/26 | | |
NCT06243731: A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation |
|
|
| Not yet recruiting | N/A | 10 | NA | No Intervention | Takeda | Cytomegalovirus (CMV), Kidney Disease, Kidney Failure | 01/27 | 01/27 | | |
